A New Inhaled Anesthetic Under Development by a Pharmaceutical Company

A new inhaled anesthetic under development by a pharmaceutical company is tested in a series of experiments to determine its pharmacokinetic properties.  During one of the experiments, the anesthetic agent is administered at a constant partial pressure while arterial and venous concentrations are monitored.  The study results show that the anesthetic has a very large arteriovenous concentration gradient shortly after beginning inhalation.  Which of the following best describes the properties of the new anesthetic?

A) Fast equilibration with the brain
B) Low peripheral tissue solubility
C) Low peripheral tissue uptake
D) Low potency
E) Slow onset of action

Correct Answer:

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Access For Free